Literature DB >> 25165027

Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.

Ioanna Skountzou1, Lakshmipriyadarshini Satyabhama2, Anastasia Stavropoulou3, Zuhha Ashraf1, E Stein Esser1, Elena Vassilieva1, Dimitrios Koutsonanos1, Richard Compans1, Joshy Jacob4.   

Abstract

Detection of immunoglobulin M (IgM) antibodies has long been used as an important diagnostic tool for identifying active viral infections, but their relevance in later stages has not been clearly defined in vivo. In this study, we followed the kinetics, longevity, and function of influenza virus-specific IgM antibodies for 2 years following sublethal infection of mice with live mouse-adapted A/PR/8/34 virus or immunization with formalin-inactivated virus. These groups mounted robust protective immune responses and survived lethal challenges with 50 × 50% lethal dose (LD50) mouse-adapted A/PR/8/34 virus 600 days after the primary exposure. Surprisingly, the virus-specific IgM antibodies persisted along with IgG antibodies, and we found a significantly higher number of IgM-positive (IgM(+)) virus-specific plasma cells than IgG(+) plasma cells that persisted for at least 9 months postexposure. The IgM antibodies were functional as they neutralized influenza virus in the presence of complement just as well as IgG antibodies did.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25165027      PMCID: PMC4248769          DOI: 10.1128/CVI.00374-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Authors:  E Szomolanyi-Tsuda; J D Brien; J E Dorgan; R L Garcea; R T Woodland; R M Welsh
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

2.  Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.

Authors:  H W Doerr; G Gross; H Schmitz
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

3.  Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody.

Authors:  K S Kim; R I Carp
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

4.  Bone marrow is a major site of long-term antibody production after acute viral infection.

Authors:  M K Slifka; M Matloubian; R Ahmed
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

Authors:  M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

6.  DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.

Authors:  Alp E Oran; Harriet L Robinson
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 7.  On natural and artificial vaccinations.

Authors:  Rolf M Zinkernagel
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

8.  Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.

Authors:  Dimitrios G Koutsonanos; Elena V Vassilieva; Anastasia Stavropoulou; Vladimir G Zarnitsyn; E Stein Esser; Misha T Taherbhai; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  Sci Rep       Date:  2012-04-12       Impact factor: 4.379

9.  Unmutated immunoglobulin M can protect mice from death by influenza virus infection.

Authors:  Yuichi Harada; Masamichi Muramatsu; Toshikatsu Shibata; Tasuku Honjo; Kazumichi Kuroda
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

10.  A critical role for induced IgM in the protection against West Nile virus infection.

Authors:  Michael S Diamond; Elizabeth M Sitati; Lindzy D Friend; Stephen Higgs; Bimmi Shrestha; Michael Engle
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  19 in total

1.  IgD+ age-associated B cells are the progenitors of the main T-independent B cell response to infection that generates protective Ab and can be induced by an inactivated vaccine in the aged.

Authors:  Olivia Kugler-Umana; Wenliang Zhang; Yi Kuang; Jialing Liang; Catherine H Castonguay; Susan L Tonkonogy; Ann Marshak-Rothstein; Priyadharshini Devarajan; Susan L Swain
Journal:  Aging Cell       Date:  2022-09-02       Impact factor: 11.005

2.  Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.

Authors:  Beth C Holbrook; Ralph B D'Agostino; Griffith D Parks; Martha A Alexander-Miller
Journal:  Vaccine       Date:  2016-08-08       Impact factor: 3.641

3.  Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection.

Authors:  Caitlin Bohannon; Ryan Powers; Lakshmipriyadarshini Satyabhama; Ang Cui; Christopher Tipton; Miri Michaeli; Ioanna Skountzou; Robert S Mittler; Steven H Kleinstein; Ramit Mehr; Frances Eun-Yun Lee; Ignacio Sanz; Joshy Jacob
Journal:  Nat Commun       Date:  2016-06-07       Impact factor: 14.919

4.  The neutralizing role of IgM during early Chikungunya virus infection.

Authors:  Chong-Long Chua; I-Ching Sam; Chun-Wei Chiam; Yoke-Fun Chan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

5.  Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.

Authors:  Angela Choi; Lorena I Ibañez; Shirin Strohmeier; Florian Krammer; Adolfo García-Sastre; Michael Schotsaert
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

6.  Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.

Authors:  Hemangi B Shah; Kenneth Smith; Edgar J Scott; Jason L Larabee; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  JCI Insight       Date:  2020-08-20

7.  Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice.

Authors:  Eunice E To; Jonathan Erlich; Felicia Liong; Raymond Luong; Stella Liong; Steven Bozinovski; Huei Jiunn Seow; John J O'Leary; Doug A Brooks; Ross Vlahos; Stavros Selemidis
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

Review 8.  How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions.

Authors:  Elena Gianchecchi; Alessandro Manenti; Otfried Kistner; Claudia Trombetta; Ilaria Manini; Emanuele Montomoli
Journal:  Influenza Other Respir Viruses       Date:  2019-06-21       Impact factor: 4.380

Review 9.  Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.

Authors:  Jing Jin; Graham Simmons
Journal:  Viruses       Date:  2019-03-28       Impact factor: 5.048

10.  Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.

Authors:  Francesco Nicoli; Mkunde Chachage; Petra Clowes; Asli Bauer; Dickens Kowour; Barbara Ensoli; Aurelio Cafaro; Leonard Maboko; Michael Hoelscher; Riccardo Gavioli; Elmar Saathoff; Christof Geldmacher
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.